MSB 3.11% $1.16 mesoblast limited

Ann: P3 Trial of MSB's Cell Therapy in CHF Completes Recruitment, page-12

  1. 7,753 Posts.
    lightbulb Created with Sketch. 2351
    We still need confirmation from the Phase 3 Trial with larger numbers, and also to know if it's better than the current standard.


    We are close, but not there yet.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.